Chairman's Statement

GlaxoSmithKline PLC
17 May 2006





Issued: Wednesday 17th May 2006


                 GLAXOSMITHKLINE EXTENDS JP GARNIER'S CONTRACT 


GlaxoSmithKline plc today announces that Chief Executive Officer Dr. JP
Garnier's contract has been extended to May 2008. Dr. Garnier's contract was set
to expire in October 2007 upon his 60th birthday.



 Sir Christopher Gent, Chairman, GlaxoSmithKline said:



"I am delighted that JP has agreed to an extension of his contract and will
continue to lead GSK for the next two years. This will maintain momentum for
GSK, in what will be an important and exciting period for the pipeline; and,
during this period, will enable the Board to complete the process for appointing
his successor."





Dr. JP Garnier said:



"I believe that the next two years will see further confirmation of GSK's strong
and innovative pipeline, with many significant filings and launches of new
medicines and vaccines.  I am proud to have the opportunity to continue leading
GSK through this very important period."






Enquiries:        UK Media                                             Philip Thomson      [phone]

                                                                       Alice Hunt          [phone]

                                                                       Gwenan Evans        [phone]

                  US Media                                             Nancy Pekarek       [phone]

                                                                       Mary Anne Rhyne     [phone]

                                                                       Patricia Seif       [phone]

                  European Analyst / Investor                          Duncan Learmouth    [phone]

                                                                       Anita Kidgell       [phone]

                                                                       Jen Hill            [phone]

                                                                       David Mawdsley      [phone]

                  US Analyst / Investor                                Frank Murdolo       [phone]

                                                                       Tom Curry           [phone]





                      This information is provided by RNS
            The company news service from the London Stock Exchange